Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duchenne Muscular Dystrophy (DMD)
Study sponsor: Kyntra Bio
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-02-13Actual
Enrollment · participants98Actual
Source updated2024-03-12Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.